Is the Low-Grade Squamous Intraepithelial Lesion/Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion Category' Associated with Cervical Intraepithelial Neoplasia 2?

被引:5
作者
Cetiner, Handan [1 ]
Kir, Gozde [2 ]
Kaygusuz, Ecmel [1 ]
Saglican, Yesim [3 ]
Kabaca, Canan [4 ]
机构
[1] Zeynep Kamil Hosp, Dept Pathol, Istanbul, Turkey
[2] Umraniye Hosp, Dept Pathol, Istanbul, Turkey
[3] Acibadem Hosp, Dept Pathol, Istanbul, Turkey
[4] Zeynep Kamil Hosp, Dept Gynecol Oncol, Istanbul, Turkey
关键词
Cervical intraepithelial neoplasia; Low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion; Bethesda system; Cervical cytology; ASC-H; CLINICAL-SIGNIFICANCE; DIAGNOSIS; HSIL; LSIL; CYTOLOGY;
D O I
10.1159/000353824
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: A number of cervical smears may exhibit unequivocal low-grade squamous intraepithelial lesions (LSIL) in association with atypical cells cytomorphologically suspicious, but not sufficient to be interpreted as high-grade squamous intraepithelial lesions (HSIL). These lesions are presently called LSIL, atypical squamous cells cannot exclude HSIL (LSIL/ASC-H). Previous studies have shown that LSIL/ASC-H and ASC-H are both equivocal for HSIL and have a high risk of underlying HSIL. However, in researching the literature only two studies were found which rendered the results as cervical intraepithelial neoplasia (CIN) 2 and CIN3 separately. The purpose of this study was to compare the distribution of biopsy results for CIN2 and CIN3 in patients with ASC-H, HSIL, and LSIL/ASC-H. Study Design: Between January 2005 and December 2011, cervicovaginal smears (98,594) with a diagnosis of ASC-H, LSIL, LSIL/ASC-H, or HSIL were re-evaluated to determine the prevalence of future lesion development. Results: A total of 252 patients who had histologic follow-up within a year were selected. Among these, LSIL/ASC-H (31.7%) had the highest prevalence of CIN2 between LSIL (9.3%), ASC-H (10%), and HSIL (16%). All differences were statistically significant. Conclusion: Because of the high predictive value of CIN2, LSIL/ASC-H may have further importance, especially in women of different age groups. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:581 / 584
页数:4
相关论文
共 17 条
[1]   Clinical Significance of the Diagnosis of Low-Grade Squamous Intraepithelial Lesion, Cannot Exclude High-Grade Squamous Intraepithelial Lesion [J].
Alsharif, Mariam ;
Kjeldahl, Klint ;
Curran, Colleen ;
Miller, Shelby ;
Gulbahce, H. Evin ;
Pambuccian, Stefan E. .
CANCER CYTOPATHOLOGY, 2009, 117 (02) :92-100
[2]   Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2 [J].
Castle, Philip E. ;
Schiffinan, Mark ;
Eeler, Cosette M. ;
Solomon, Diane .
OBSTETRICS AND GYNECOLOGY, 2009, 113 (01) :18-25
[3]   Comparison of the Clinical Significance of the Papanicolaou Test Interpretations LSIL Cannot Rule Out HSIL and ASC-H [J].
Difurio, Megan J. ;
Mailhiot, Thomas ;
Sundborg, Michael J. ;
Nauschuetz, Karen K. .
DIAGNOSTIC CYTOPATHOLOGY, 2010, 38 (05) :313-317
[4]   The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests [J].
Elsheikh, Tarik M. ;
Kirkpatrick, Joseph L. ;
Wu, Howard H. .
CANCER CYTOPATHOLOGY, 2006, 108 (05) :277-281
[5]   The Utility of 'Low-Grade Intraepithelial Lesion, Cannot Exclude High Grade' Diagnosis: A Single Institution's Experience [J].
Finkelstein, Alexander ;
Bajor-Dattilo, Ewa B. ;
Yang, Michael C. ;
Szeto, Oliver ;
Zhou, Fang ;
Elgert, Paul ;
Das, Kasturi .
ACTA CYTOLOGICA, 2012, 56 (04) :383-387
[6]   Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H [J].
Hunter, C. ;
Duggan, M. A. ;
Duan, Q. ;
Power, P. ;
Gregoire, J. ;
Nation, J. .
CYTOPATHOLOGY, 2009, 20 (01) :17-26
[7]   Lsil/Asc-H (Lsil-H) in Cervicovaginal Smear: Histopathological Outcomes and Clinical Significance [J].
Kaygusu, Ecmel Isik ;
Cetiner, Handan ;
Sahin, Davut .
TURKISH JOURNAL OF PATHOLOGY, 2011, 27 (01) :46-50
[8]  
Kir G, 2004, EUR J GYNAECOL ONCOL, V25, P462
[9]   Is the treatment of CIN 2 always necessary in women under 25 years old? [J].
McAllum, Bree ;
Sykes, Peter H. H. ;
Sadler, Lynn ;
Macnab, Helene ;
Simcock, Bryony J. ;
Mekhail, Adel K. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (05) :478.e1-478.e7
[10]  
Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17